SCHEMBL2860448

SCHEMBL2860448

COC(=O)Cc1cc(O)cc(O)c1C(=O)c1ccc(O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.49
HSP90AB1 P08238 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
POLB P06746 1/20 0.45
SYNJ2 O15056 1/20 0.44
NR4A1 P22736 1/20 0.43
ALDH1A1 P00352 3/20 0.43
GAA P10253 3/20 0.43
KDM4E B2RXH2 1/20 0.43
GLA P06280 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
HPGD P15428 3/20 0.42
CYP3A4 P08684 2/20 0.42
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2859379 0.90 SLC5A1 (0.50) EGFRHSP90AB1MEN1KMT2APOLB
SCHEMBL2862203 0.83 CYP2D6 (0.54) MEN1KMT2APOLBALDH1A1GAA
SCHEMBL2863766 0.81 MEN1 (0.68) EGFRHSP90AB1MEN1KMT2APOLB
SCHEMBL2861394 0.76 SLC22A12 (0.40) EGFRHSP90AB1SYNJ2ALDH1A1GAA
SCHEMBL30605142 0.76 EGFR (0.75) EGFRHSP90AB1ALDH1A1GAAKDM4E
SCHEMBL8764395 0.76 EGFR (0.57) EGFRHSP90AB1MEN1KMT2APOLB
SCHEMBL30619656 0.76 EGFR (0.57) EGFRHSP90AB1MEN1KMT2APOLB
SCHEMBL3545527 0.76 EGFR (0.75) EGFRHSP90AB1ALDH1A1GAAKDM4E
Iriflophenone SCHEMBL9148205 0.75 FASN (0.67) MEN1KMT2APOLBSYNJ2ALDH1A1
SCHEMBL27661252 0.74 CYP4F2 (0.56) HSP90AB1MEN1KMT2AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7767693-B2 Hsp90 family protein inhibitors KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-08-03 US disclosed
CN-100567242-C Hsp90 family protein blockers KYOWA HAKKO KOGYO KK (JP) 2009-12-09 CN disclosed
US-20090247522-A1 Hsp90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-10-01 US disclosed
US-7538224-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070032532-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-02-08 US disclosed
CN-1791568-A Hsp90 family protein inhibitors KYOWA HAKKO KOGYO KK (JP) 2006-06-21 CN disclosed
EP-1642880-A1 HSP90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-04-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032532-A1 Hsp90 family protein inhibitors HSP90AB1, HSP90B1, HSP90AB2P EGFR 832/4885HSP90AB1 1/4885MEN1 4773/4885
US-20090247522-A1 Hsp90 FAMILY PROTEIN INHIBITORS HSP90AB1, HSP90B1, HSP90AB2P EGFR 832/4885HSP90AB1 1/4885MEN1 4773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.